Parkside Financial Bank & Trust Biotechnology

Parkside Financial Bank & Trust

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
SANA Sana Biotechnology, Inc.	$770M	$0 0.0% of portfolio	145	Q1 2025 New
SRRK Scholar Rock Holding Corp	$1.74B	$0 0.0% of portfolio	30	Q1 2025 New
SLS Sellas Life Sciences Group, Inc.	$43M	$0 0.0% of portfolio	2	Q2 2022 New
STOK Stoke Therapeutics, Inc.	$461M	$0 0.0% of portfolio	50	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$523M	$0 0.0% of portfolio	40	Q1 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.07B	$0 0.0% of portfolio	10	Q1 2025 New
TRVI Trevi Therapeutics, Inc.	$343M	$0 0.0% of portfolio	140	Q1 2025 New
PCVX Vaxcyte, Inc.	$2.12B	$0 0.0% of portfolio	5	Q1 2025 New
VERA Vera Therapeutics, Inc.	$619M	$0 0.0% of portfolio	20	Q1 2025 New
VERV Verve Therapeutics, Inc.	$669M	$0 0.0% of portfolio	70	Q1 2025 New
VIR Vir Biotechnology, Inc.	$787M	$0 0.0% of portfolio	92	Q1 2025 Added 155.56%
XERS Xeris Biopharma Holdings, Inc.	$636M	$0 0.0% of portfolio	155	Q1 2025 New

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.